**Author details**

Lara García-Álvarez and José Antonio Oteo\* San Pedro University Hospital - Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain

\*Address all correspondence to: jaoteo@riojasalud.es

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**79**

Tropheryma whipplei *Endocarditis*

[1] Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H,, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med. 2000;342:620-625.DOI: 10.1056/ NEJM200003023420903.

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.95378*

[9] Yardley JH, Hendrix TR. Combined electron and light microscopy in Whipple's disease. Bulletin of the Johns Hopkins Hospital. 1961;**109**:80-98

[11] Cohen AS, Schimmel EM, Holt PR,

[10] Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's-disease-associated bacterium. Lancet. 1991;**338**:474-475. DOI: 10.1016/0140-6736(91)90545-z

Isselbacher KJ. Ultrastructural abnormalities in Whipple's

disease. Proceedings of the Society for Experimental Biology and Medicine. 1960;**105**:411-414. DOI: 10.3181/00379727-105-26126

[12] Schoedon G, Goldenberger D, Forrer R, Gunz A, Dutly F, Höchli M, et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. The Journal of Infectious Diseases. 1997;**176**:672-

[13] Raoult D, Ogata H, Audic S, Robert C, Suhre K, Drancourt M. Tropheryma whipplei twist: A human pathogenic actinobacteria with a reduced genome. Genome Research. 2003;**13**:1800-1809.

677. DOI: 10.1086/514089

DOI: 10.1101/gr.1474603

[14] Bentley SD, Maiwald M, Murphy LD, Pallen MJ, Yeats CA, Dover LG, et al. Sequencing and analysis of the genome of the Whipple's

disease bacterium Tropheryma whipplei. Lancet. 2003;**361**:637-644. DOI: 10.1016/S0140-6736(03)12597-4

[15] Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrobial

[16] Boulos A, Rolain JM, Mallet MN, Raoult D. Molecular evaluation of

Agents and Chemotherapy. 2004;**48**:747-752. DOI: 10.1128/

aac.48.3.747-752.2004

[2] Dutly F, Altwegg M. Whipple's disease and "Tropheryma whippelii". Clinical Microbiology Reviews. 2001;**14**:561-583. DOI: 10.1128/CMR.14.3.561-583.2001

Identification of the uncultured bacillus of Whipple's disease. The New England Journal of Medicine. 1992;**327**:293-301. DOI: 10.1056/NEJM199207303270501

[4] La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D. Description of Tropheryma whipplei gen. Nov., sp. nov., the Whipple's disease bacillus. International Journal of Systematic and Evolutionary Microbiology. 2001;**51**:1471-1479. DOI:

[5] Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bulletin of the Johns Hopkins

[3] Relman DA, Schmidt TM, MacDermott RP, Falkow S.

10.1099/00207713-51-4-1471

Hospital. 1907;**18**:382-393

[6] Black-Schaffer B. The tinctoral demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol. 1949;**72**:225-227. DOI: 10.3181/00379727-72-17388

[7] Paulley JW. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology. 1952;**22**:128-133

[8] WJr C, Ashworth CT. Electron microscopy study of the intestinal mucosa in Whipple's diseasedemonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;**41**:129-138 Tropheryma whipplei *Endocarditis DOI: http://dx.doi.org/10.5772/intechopen.95378*
